The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of PDMR Options

18 Dec 2020 10:30

RNS Number : 1572J
DeepMatter Group PLC
18 December 2020
 

18 December 2020

 

DeepMatter Group plc

 

("DeepMatter", the "Company" or "the Group")

 

Grant of Options

 

DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, announces that options over a total of 5,000,000 ordinary shares have been granted to Fraser Benson, Chief Financial Officer, under the Share Option Plan 2017 ("Options"). The exercise price of the Options is 2.5p, aligned with those issued to the management team in 2019 under the same scheme. Provided Fraser Benson remains an employee, his options vest over 36 months starting from 1 February 2021 subject to the specific share price triggers set out in the table below being reached. All unexercised options lapse after 10 years from the date of grant.

 

Share Price Trigger (£)

Number of plan shares in respect of which the Options may be exercised

None

1,666,656

0.04

1,111,112

0.06

277,778

0.08

277,778

0.10

277,778

0.12

277,778

0.14

277,778

0.16

277,778

0.18

277,778

0.20

277,775

 

 

For more information, please contact:

DeepMatter Group plc

T: 0141 548 8156

Mark Warne, Chief Executive Officer

 

 

 

 

Canaccord Genuity Limited (Nominated Advisor and Broker)

 

T: 020 7523 8000

Bobbie Hilliam / Angelos Vlatakis

 

 

Alma PR

T: 020 3405 0205

Caroline Forde / Harriet Jackson / Kieran Breheny

deepmatter@almapr.co.uk

 

About DeepMatter Group plc 

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. It has developed and is commercialising data rich platform technologies, including software and laboratory hardware, focused on applications to improve R&D productivity and discovery using Machine Learning / Artificial Intelligence. 

 

DeepMatter's technologies allow chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. They are designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster. 

 

Visit: www.deepmatter.io and follow @deepmattergroup

 

1

Details of the person discharging managerial responsibilities / person closely associated 

a) 

Name

Fraser Benson

2

Reason for the notification 

a)

Position/status

Chief Financial Officer

b) 

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) 

Name

DeepMatter Group plc

b) 

LEI

213800WSAEORFSGUAB87

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.01 pence each

Identification code

ISIN: GB00B29YYY86

b) 

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.5p

5,000,000

d)

 

Aggregated information

- Aggregated volume

- Price

- Total

 

N/A

e)

Date of the transaction 

17 December 2020

f) 

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUWSKRRVUUARA
Date   Source Headline
25th Jul 20084:44 pmRNSResult of AGM
30th Jun 20087:00 amRNSAudited Final Results
4th Jun 200812:50 pmRNSCollaborative Research and De
19th May 20082:07 pmRNSChange of Company Secretary a
15th Apr 200810:47 amRNSJoint Development Agreement
7th Apr 20083:52 pmRNSBusiness Update
28th Mar 200812:36 pmRNSHolding(s) in Company
17th Mar 20082:00 pmRNSHolding(s) in Company
5th Mar 20085:22 pmRNSAward of Share Options-Amend
3rd Mar 20081:23 pmRNSAward of Share Options
27th Feb 20087:01 amRNSAppointment of Director
11th Feb 200811:46 amRNSHolding(s) in Company
16th Jan 20081:52 pmRNSChange of Accounting Ref Date
10th Jan 200810:48 amRNSHolding(s) in Company
8th Jan 200811:46 amRNSHolding(s) in Company
31st Dec 20078:00 amRNSAdmission to AIM
27th Dec 200712:11 pmRNSHolding(s) in Company
21st Dec 20072:46 pmRNSGeneral Meeting
19th Dec 20078:00 amRNSShort Notice General Meeting
13th Dec 20072:36 pmRNSSchedule 1 - Kanyon plc
13th Dec 20071:39 pmRNSAdmission Document
12th Dec 20076:31 pmRNSAcquisition
25th Oct 20077:01 amRNSInterim Results
17th Aug 20077:01 amRNSAIM Rule 26 Website
29th Jun 20079:00 amRNSTotal Voting Rights
3rd May 200712:37 pmRNSAppointment of Directors
30th Apr 200710:15 amRNSEGM Statement
30th Apr 200710:08 amRNSAGM Statement
4th Apr 20072:48 pmRNSFinal Results
28th Mar 20071:44 pmRNSAcquisition
20th Dec 200611:53 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.